06/19/2026
We are so grateful for our Presenting Sponsor, GRIN Therapeutics! ππ
Their generous support of the GRIN2B Family & Research Weekend makes it possible for our families, researchers, and clinicians to come together in one place, connecting, learning, and building hope.
GRIN Therapeutics is leading the charge to develop the first targeted treatment for GRIN-related neurodevelopmental disorders. Their investigational therapy, radiprodil, is currently in a global Phase 3 clinical trial enrolling patients in the US, UK, and Europe, bringing our community closer than ever to a real treatment. π
Thank you, GRIN Therapeutics. We are honored to have you by our side. π
Learn more about the 2026 GRIN2B Family & Research Weekend.
https://grin2b.com/family-research-weekend-2026/